CpG DNA as a Th1-promoting adjuvant in immunization against Trypanosoma cruzi

Vaccine

Volumn 19, Issue 2-3, 2000, Pages 234-242

  Corral, Ricardo S ^a   Petray, Patricia B ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

CpG oligodeoxynucleotide; Th1 response; Trypanosoma cruzi

Indexed keywords

GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 2; OLIGODEOXYNUCLEOTIDE; PARASITE ANTIBODY; PARASITE ANTIGEN; TRYPANOSOMA CRUZI VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; CPG ISLAND; DELAYED HYPERSENSITIVITY; DRUG POTENTIATION; IMMUNOPROPHYLAXIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE;

EID: 0034666740     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00172-9     Document Type: Article

References (42)

1. Tropical disease research. Progress 1975-94. Twelfth programme report of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva, Switzerland, 1995. p. 125-34.
2. Basombrío M.A. Trypanosoma cruzi: partial prevention of the natural infection of guinea pigs with a killed parasite vaccine. Exp. Parasitol. 71:1990;1-8.
3. Neal R.A., Johnson P. Immunization against Trypanosoma cruzi using killed antigens and with saponin as adjuvant. Acta Trop. 34:1997;87-96.
4. Basombrío M.A., Arredes H. Long-term immunological response induced by attenuated Trypanosoma cruzi in mice. J. Parasitol. 73:1987;236-241.
5. Andrews N.W., Alves M.J.M., Schumacher R.I., Colli W. Trypanosoma cruzi: protection in mice immunized with 8-methoxypsoralen-inactivated trypomastigotes. Exp. Parasitol. 60:1985;255-262.
6. Segura E.L., Vazquez C., Bronzina A., Campos J.M., Cerisola J.A., Gonzalez, Cappa S.M. Antigens of the subcellular fractions of Trypanosoma cruzi. Part II: Flagellar and membrane fraction. J. Protozool. 24:(4):1977;540-543.
7. Rottenberg M.E., Cardoni R.L., De Titto E.H., Moreno M., Segura E.L. Trypanosoma cruzi: immune response in mice immunized with parasite antigens. Exp. Parasitol. 65:1988;101-108.
8. Scott M.T., Bahr G., Moddaber F., Afchain D., Chedid L. Adjuvant requirements for protective immunization of mice using a Trypanosoma cruzi 90 K cell surface glycoprotein. Int. Archs. Allergy. Appl. Immun. 74:1984;373-377.
9. Quanquin N.M., Galaviz C., Fouts D.L., Wrightsman R.A., Manning J.E. Immunization of mice with a TolA-like surface protein of Trypanosoma cruzi generates CD4 + T-cell-dependent parasiticidal activity. Infect. Immun. 67:(9):1999;4603-4612.
10. Bua J., Bontempi E.J., Levin M., Örn A., Velasco D., Moreno M., Levi-Yeyati P., Engstrom A., Segura E.L., Ruiz A.M. Trypanosoma cruzi: cellular and antibody response against the parasite in mice immunized with a 19-amino acid synthetic peptide. Exp. Parasitol. 72:(1):1991;54-62.
11. Wizel B., Garg N., Tarleton R.L. Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection. Infect. Immun. 66:(11):1998;5073-5081.
12. Bombord R., McHardy N. Corynebacterium parvum as an adjuvant for Trypanosoma cruzi epimastigote vaccines: a comparison with saponin and Bordetella pertussis. Parasitology. 78:1979;77-97.
13. Ruiz A.M., Esteva M., Riarte A., Subías E., Segura E.L. Immunoprotection of mice against Trypanosoma cruzi with a lyophilized flagellar fraction of the parasite plus adjuvant. Immunol. Lett. 12:1986;1-4.
14. Williams D.L., Yaeger R.G., Pretus H.A., Browder W., McNamee R.B., Jones E.L. Immunization against Trypanosoma cruzi: adjuvant effect of glucan. Int. J. Immunopharmac. 11(4):1989;403-410.
15. Kierszenbaum F., Ferraresi R. Enhancement of host resistance against Trypanosoma cruzi infection by the immunoregulatory agent muramyl dipeptide. Infect. Immun. 25:1979;273-278.
16. Araujo F.G., Morein B. Immunization with Trypanosoma cruzi epimastigote antigens incorporated into iscoms protects against lethal challenge in mice. Infect. Immun. 59:(9):1991;2909-2914.
17. Miller M.J., Wrightsman R.A., Manning J.E. Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response. Exp. Parasitol. 84:1996;156-167.
18. Weiner G.J., Liu H., Wooldridge J.E., Dahle C.E., Krieg A.M. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc. Natl. Acad. Sci. USA. 94:1997;10833-10837.
19. Krieg A.M., Love-Homan L., Yi A.K., Harty J.T. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. Immunol. 161:1998;2428-2434.
20. Davis H.L., Weeranta R., Waldschmidt T.J., Tygrett L., Schorr J., Krieg A.M. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160:1998;870-876.
21. Moldoveanu Z., Love-Homan L., Huang W.Q., Krieg A.M. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine. 16:1998;1216-1224.
22. Zimmermann S., Egeter O., Hausmann S., Lipford G.B., Röcken M., Wagner H., Heeg K. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J. Immunol. 160:1998;3627-3630.
23. Stacey K.J., Blackwell J.M. Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major. Infect. Immun. 67:(8):1999;3719-3726.
24. Walker P.S., Scharton-Kersten T., Krieg A.M., Love-Homan L., Rowton E.D., Udey M.C., Vogel J.C. Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-γ-dependent mechanisms. Proc. Natl. Acad. Sci. USA. 96:1999;6970-6975.
25. Jones T.R., Obaldia III, N., Gramzinski R.A., Charoenvit Y., Kolodny N., Kitov S., Davis H.L., Krieg A.M., Hoffman S.L. Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys. Vaccine. 1:1999;3065-3071.
26. Klinmann D.M., Barnhart K.M., Conover J. CpG motifs as immune adjuvants. Vaccine. 17:1999;19-25.
27. Lipford G.B., Heeg K., Wagner H. Bacterial DNA as immune cell activator. Trends Microbiol. 6:(12):1998;496-500.
28. Bird A.P. CpG islands as gene markers in the vertebrate nucleus. Trends Genet. 3:1987;342-347.
29. Krieg A.M., Yi A-K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549.
30. Yi A-K., Klinman D.M., Martin T.L., Matson S., Krieg A.M. Rapid immune activation by CpG motifs in bacterial DNA: systemic induction of IL-6 transcription through an antioxidant sensitive pathway. J. Immunol. 157:1996;5394-5402.
31. Yi A-K., Chang M., Peckham D.W., Krieg A.M., Ashman R.F. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J. Immunol. 160:1998;5898-5906.
32. Krieg A.M., Yi A-K., Schorr J., Davis H.L. The role of CpG dinucleotides in DNA vaccines. Trends Microbiol. 6:(1):1998;23-27.
33. Ballas Z.K., Rasmussen W.L., Krieg A.M. Induction of natural killer activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157:1996;1840-1845.
34. Chace J.H., Hooker N.A., Mildenstein K.L., Krieg A.M., Cowdery J.S. Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12. Clin. Immunol. Immunopath. 84:1997;185-193.
35. Roman M., Martin-Orozco E., Goodman J.S., et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nature Med. 3:(8):1997;849-854.
36. Sparwasser T, Koch EV-, Vabulas R.M., et al. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28:1998;2045-2054.
37. Stacey J.J., Sweet M.J., Hume D.A. Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157:1996;2116-2122.
38. Reiner S.L., Locksley R.M. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:1995;151-177.
39. Reed S.G. Immunology of Trypanosoma cruzi infections. Liew F.Y., Cox F.E.G. Immunology of intracellular parasitism. 1998;124-143 Karger, Basel.
40. Chu R.S., Targoni O.S., Krieg A.M., Lehmann P.V., Harding C.V. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186:(10):1997;1623-1631.
41. Powell M.R., Wasson D.L. Host genetics and resistance to acute Trypanosoma cruzi infection in mice. Part I: Antibody isotype profiles. Parasite Immunol. 15:1993;215-221.
42. Petray P.B., Castaños-Vélez E., Grinstein S., Örn A., Rottenberg M.E. Role of nitric oxide in resistance and histopathology during experimental infection with Trypanosoma cruzi. Immunol. Lett. 47:1995;121-126.